These drugs were originally prescribed to patients with Type 2 diabetes as they produce insulin and lower blood sugar
Similar to depression, diabetic patients prescribed any of the GLP-1 medications had a lower likelihood of being diagnosed with anxiety after starting the medication compared to those not prescribed a GLP-1 medication
Taken together, this emphasizes the importance in timely initiation of GLP-1RA, targeting the primary preventive population with overweight/obesity, prior to the manifestation of T2DM and development of ASCVD [92,93,94,95]
Researchers have investigated that curcumin has the potential to treat various disorders and can be an effective therapeutic agent for regulating and treating cancer ailments like depression, pain, insomnia, and neuro-degeneration [311]
10.1016/j.febslet.2014.08.029 [DOI] [PubMed] [Google Scholar] 4.Lamers D, Famulla S, Wronkowitz N, Hartwig S, Lehr S, Ouwens DM, et al
Refining the link between obesity and heart failure: insights from GLP-1 receptor agonist trials and studies adopting direct adiposity measures